Literature DB >> 9005895

Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis.

C J Glueck1, R Freiberg, T Tracy, D Stroop, P Wang.   

Abstract

In 31 patients with osteonecrosis (primarily of the hip), 74% had 1 or more primary coagulation disorders. In 18 patients, 15 (83%) who had coagulation disorders, the osteonecrosis was initially identified as idiopathic and was not associated with known underlying drugs (glucocorticoids) or diseases (alcoholism, sickle cell disease, Gaucher's disease). In 13 patients, 8 (62 %) who had coagulation disorders, the osteonecrosis was initially identified as secondary, and was associated with glucocorticoids in 12 patients, and with alcoholism in 1. The coagulation disorders included thrombhophilia (increased tendency to intravascular thrombosis) and hypofibrinolysis (reduced ability to lyse thrombi). Of the 18 patients initially thought to have idiopathic osteonecrosis, thrombophilia alone was found in 12% (resistance to activated protein C in 6%, low protein C in 6%), hypofibrinolysis alone was found in 50% (high lipoprotein(a) in 44%, low stimulated tissue plasminogen activator activity was found in 6%), and mixed thrombophilia hypofibrinolysis was found in 22%. Resistance to activated protein C was more common in these 18 patients than in healthy controls (11% versus 0%), as was high lipoprotein(a) (67% versus 20%). Of the 13 patients with secondary osteonecrosis, thrombophilia alone was found in 8% (low protein C), hypofibrinolysis alone was found in 30% (high Lp(a) in 15%, low tissue plasminogen activator activity in 15%), and mixed thrombophilia hypofibrinolysis was found in 23%. Low tissue plasminogen activator activity was more common in the 13 patients with secondary osteonecrosis than in controls (27% versus 7%), as was low protein C (23% versus 0%). In aggregate, these findings lead us to the speculation that primary, heritable thrombophilia or hypofibrinolysis causes thrombotic venous occlusion in the head of the femur, leading to venous hypertension and hypoxic death of bone (osteonecrosis).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9005895

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  33 in total

1.  Bilateral osteonecrosis of the tarsus coincident with glioblastoma multiforme.

Authors:  M Heliotis; E Tsiridis; S T Donell; T J Marshall; D G Scott
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

2.  Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.

Authors:  Salvatore Ruggiero; Julie Gralow; Robert E Marx; Ana O Hoff; Mark M Schubert; Joseph M Huryn; Bela Toth; Kathryn Damato; Vicente Valero
Journal:  J Oncol Pract       Date:  2006-01       Impact factor: 3.840

3.  MicroRNA-mediated interacting circuits predict hypoxia and inhibited osteogenesis of stem cells, and dysregulated angiogenesis are involved in osteonecrosis of the femoral head.

Authors:  Gour-Shenq Kao; Yuan-Kun Tu; Pei-Hsun Sung; Feng-Sheng Wang; Yu-Der Lu; Chen-Ta Wu; Rio L C Lin; Hon-Kan Yip; Mel S Lee
Journal:  Int Orthop       Date:  2018-04-26       Impact factor: 3.075

Review 4.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

5.  Genetic association of the ApoB and ApoA1 gene polymorphisms with the risk for alcohol-induced osteonecrosis of femoral head.

Authors:  Yuan Wang; Yuju Cao; Yizhou Li; Yongchang Guo; Quanjian Wang; Min Yang; Ning Zhang; Tianbo Jin; Jianzhong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

6.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

7.  Heritable thrombophilia-hypofibrinolysis and osteonecrosis of the femoral head.

Authors:  Charles J Glueck; Richard A Freiberg; Ping Wang
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

8.  Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population.

Authors:  Jun-Dong Chang; Mina Hur; Sang-Soo Lee; Je-Hyun Yoo; Kyu Man Lee
Journal:  Clin Orthop Relat Res       Date:  2008-03-19       Impact factor: 4.176

9.  Differential expression of vascular endothelial growth factor in glucocorticoid-related osteonecrosis of the femoral head.

Authors:  Deike Varoga; Wolf Drescher; Melanie Pufe; Godo Groth; Thomas Pufe
Journal:  Clin Orthop Relat Res       Date:  2009-12       Impact factor: 4.176

10.  Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13.

Authors:  Wei-Ming Chen; Yu-Fen Liu; Ming-Wei Lin; I-Chun Chen; Pei-Yu Lin; Guan-Lu Lin; Yuh-Shan Jou; Yang-Te Lin; Cathy S J Fann; Jer-Yuarn Wu; Kwang-Jen Hsiao; Shih-Feng Tsai
Journal:  Am J Hum Genet       Date:  2004-06-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.